Cohort Study of the Clinical Course of Macular Diseases in Japanese
Information source: Kyoto University, Graduate School of Medicine
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Macular Disease
Intervention: ranibizumab, aflibercept, pegaptanib, verteporphin (Drug)
Phase: N/A
Status: Recruiting
Sponsored by: Kyoto University, Graduate School of Medicine Official(s) and/or principal investigator(s): Nagahisa Yoshimura, MD, Study Chair, Affiliation: Kyoto University, Graduate School of Medicine
Overall contact: Akitaka Tsujikawa, MD, Phone: +81-75-751-3260, Email: tujikawa@kuhp.kyoto-u.ac.jp
Summary
Recent clinical introduction of anti-vascular endothelial growth factor agents may change
the clinical course of macular diseases, including age-related macular degeneration (AMD),
polypoidal choroidal vasculopathy (PCV), retinal angiomatous proliferation (RAP), central
serous chorioretinopathy (CSC), myopic choroidal neovascularization (CNV), retinal vein
occlusion (RVO), diabetic macular edema (DME), and so forth.
Patients with such macular diseases are registered and and are followed up for 5 years with
appropriate treatment for each patient. By the analysis of the correlation between initial
examinations and final visual acuity, factors associated with good visual prognosis will be
elucidated.
Clinical Details
Official title: Cohort Study of the Clinical Course of Macular Diseases in Japanese Patients
Study design: Observational Model: Cohort, Time Perspective: Prospective
Primary outcome: Initial factors associated with visual prognosis in each macular disease
Secondary outcome: The difference in the visual prognosis depending on the treatments in each macular diseases
Eligibility
Minimum age: N/A.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Patients who visit Department of Ophthalmology Kyoto University Hospital with macular
diseases.
- Patients who are agreed with the participation of this study.
Exclusion Criteria:
- None
Locations and Contacts
Akitaka Tsujikawa, MD, Phone: +81-75-751-3260, Email: tujikawa@kuhp.kyoto-u.ac.jp
Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan; Recruiting Misao Ogaki, Phone: +81-75-751-3248, Email: misao@kuhp.kyoto-u.ac.jp Akitaka Tsujikawa, MD, Principal Investigator
Additional Information
Starting date: March 2014
Last updated: March 6, 2014
|